The Global Health Observatory

Explore a world of health data

Appears in:
Map
Table
Indicator name:
Syphilis, antenatal care attendees positive for syphilis who received treatment (%), reported
Short name:
Pregnant women in ANC treated for syphilis
Data type:
Percent
Indicator Id:
3777
Topic:
Health service coverage
Health systems resources
Rationale:
Testing (screening) coverage, the prevalence of syphilis in women attending antenatal care services, and treatment coverage are all key indicators for assessing a country’s progress towards eliminating vertical transmission of syphilis. At the country level, these data can be used to identify areas with the greatest need for comprehensive congenital syphilis prevention interventions. At the global level, these data are also used to estimate the perinatal mortality and morbidity caused by syphilis that could be averted with effective programmes to eliminate vertical transmission of syphilis. Treating antenatal care attendees who test positive for syphilis is essential for reducing vertical transmission of syphilis.
Definition:
 Percentage of women attending antenatal care services who had a positive syphilis serology and who were treated adequately.
Numerator: Number of women attending antenatal care services with a positive syphilis test who received at least one dose of benzathine penicillin 2.4 million units intramuscularly.
Denominator: Number of women attending antenatal care services who tested positive for syphilis.
Method of measurement
Pregnant women with positive syphilis serology should be treated with benzathine penicillin, ideally on the same day as they are tested in order to prevent vertical transmission. For the purposes of this indicator, documentation of a single dose of penicillin is sufficient. Treatment of syphilis in pregnant women should be based on national treatment guidelines. Knowledge of treatment policies and practices should be used to interpret trends in treatment.
M&E Framework:
Process
Method of estimation:
Country reports to Global AIDS Monitoring (GAM) process (formerly Global AIDS response progress reporting (GARPR))
Other possible data sources:
Special studies
Preferred data sources:
Routine health information systems
Unit of Measure:
Not applicable
Expected frequency of data dissemination:
Annual
Expected frequency of data collection:
Annual
Comments:
None
Contact person email:
jrowley@who.int
Name:
Jane Rowley
Links:
Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus
WHO guideline on syphilis screening and treatment for pregnant women
Dual HIV/syphilis rapid diagnostic tests can be used as the first test in antenatal care
Indicator Metadata Registry List
antenatal care attendees positive for syphilis who received treatment (%), reported
If you have any feedback, you are welcome to write it here.
If you need to access the old Global Health Observatory data, you can do it here. But before you leave, please provide us your feedback about our new data portal.